{"id":259350,"date":"2019-01-08T10:59:44","date_gmt":"2019-01-08T09:59:44","guid":{"rendered":"http:\/\/www.pcnen.com\/portal\/?p=259350"},"modified":"2019-01-08T10:59:44","modified_gmt":"2019-01-08T09:59:44","slug":"rusija-novi-lijek-protiv-astme","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2019\/01\/08\/rusija-novi-lijek-protiv-astme\/","title":{"rendered":"Rusija: Novi lijek protiv astme"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-187243\" src=\"http:\/\/www.pcnen.com\/portal\/wp-content\/uploads\/2015\/08\/astma.jpg\" alt=\"\" width=\"200\" height=\"153\" srcset=\"https:\/\/www.pcnen.com\/portal\/wp-content\/uploads\/2015\/08\/astma.jpg 200w, https:\/\/www.pcnen.com\/portal\/wp-content\/uploads\/2015\/08\/astma-75x57.jpg 75w\" sizes=\"(max-width: 200px) 100vw, 200px\" \/>Ruski nau\u010dnici su napravili preparat koji blokira jedan od glavnih mehanizama astme \u2014 hroni\u010dno zapaljenje sinusa, pi\u0161e list Izvestija, prenosi Sputnjik.<\/p>\n<p>Preparat je pro\u0161ao preklini\u010dko testiranje. Stru\u010dnjaci su dokazali da inhalaciono kori\u0161c\u0301enje te supstance dovodi do zna\u010dajnog smanjenja zapaljenja bronhijalnog tkiva.<\/p>\n<p>Kako je objasnio direktor Instituta Musa Haitov, supstanca na molekularnom nivou blokira sintezu proteina \u2018krivca\u2019 za upalu \u2014 interleukina IL-4, koji pokrec\u0301e proces razvoja alergije.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ruski nau\u010dnici su napravili preparat koji blokira jedan od glavnih mehanizama astme \u2014 hroni\u010dno zapaljenje sinusa, pi\u0161e list Izvestija, prenosi Sputnjik. Preparat je pro\u0161ao preklini\u010dko testiranje. Stru\u010dnjaci su dokazali da inhalaciono kori\u0161c\u0301enje te supstance dovodi do zna\u010dajnog smanjenja zapaljenja bronhijalnog tkiva. Kako je objasnio direktor Instituta Musa Haitov, supstanca na molekularnom nivou blokira sintezu proteina [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":187243,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-259350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/259350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=259350"}],"version-history":[{"count":0,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/259350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/187243"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=259350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=259350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=259350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}